Add Yahoo as a preferred source to see more of our stories on Google. KINGSPORT, Tenn. (WJHL) – On Wednesday, Holston Valley Medical Center (HVMC) successfully performed a cardiac ablation procedure ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BTIG analysts remain high on Boston Scientific (NYSE:BSX) following meetings with the company's management this week.
Boston Scientific's FARADISE registry study is due to run for another two years before its completion in 2027. Image credit: Mehaniq via Shutterstock.com. · Medical Device Network · Mehaniq via ...
Narrow-moat Boston Scientific’s BSX long-awaited clinical data on its Farapulse pulsed field ablation, or PFA, device for atrial fibrillation didn’t disappoint, and we’ve raised our fair value ...
In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Allan Zingeler, Raju Viswanathan, PhD, and Michael Mahoney of Boston Scientific have been awarded the inaugural Thomas J. Fogarty Prize (Fogarty Prize) for the ...
Boston Scientific, Inc. BSX recently gained the FDA’s approval for the FARAPULSE Pulsed Field Ablation (“PFA”) system, which is indicated for the isolation of pulmonary veins in the treatment of ...
Dr. Steven Mickelsen dreamed up a new way to treat a heart condition called atrial fibrillation while finishing a medical fellowship at the University of Iowa in 2012. His idea of using pulsed ...
Editor's note: This is the first of a two-part series on the Boston Scientific Investor Day presentation. This first part focuses on the company's Farapulse pulsed field ablation system. Part two will ...
Boston Scientific Corp BSX will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August. ADVENT ...
MARLBOROUGH, Mass. and AMSTERDAM, Aug. 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results